115 related articles for article (PubMed ID: 24305729)
1. Improving bioavailability with a novel isotretinoin formulation (isotretinoin-Lidose).
Tan J; Knezevic S
Skin Therapy Lett; 2013; 18(6):1-3. PubMed ID: 24305729
[TBL] [Abstract][Full Text] [Related]
2. Comparative pharmacokinetic profiles of a novel isotretinoin formulation (isotretinoin-Lidose) and the innovator isotretinoin formulation: a randomized, 4-treatment, crossover study.
Webster GF; Leyden JJ; Gross JA
J Am Acad Dermatol; 2013 Nov; 69(5):762-767. PubMed ID: 23953888
[TBL] [Abstract][Full Text] [Related]
3. Comparative Pharmacokinetic Profiles of a Novel Low-dose Micronized-isotretinoin 32 mg Formulation and Lidose-isotretinoin 40 mg in Fed and Fasted Conditions: Two Open-label, Randomized, Crossover Studies in Healthy Adult Participants.
Madan S; Kumar S; Segal J
Acta Derm Venereol; 2020 Feb; 100(4):adv00049. PubMed ID: 31774544
[TBL] [Abstract][Full Text] [Related]
4. ARTICLE: Advances in Oral Isotretinoin Therapy.
Jones M; Armstrong AW; Baldwin H; Stein Gold L; Kircik LH
J Drugs Dermatol; 2021 May; 20(5):s5-s11. PubMed ID: 33938693
[TBL] [Abstract][Full Text] [Related]
5. Results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne.
Webster GF; Leyden JJ; Gross JA
J Drugs Dermatol; 2014 Jun; 13(6):665-70. PubMed ID: 24918555
[TBL] [Abstract][Full Text] [Related]
6. Comparative bioequivalence study of two isotretinoin soft gel capsule formulations in healthy male volunteers.
Georgarakis M; Zougrou F; Tzavara S; Kontopoulos G; Tsiptsios I
Int J Clin Pharmacol Ther; 2003 Jul; 41(7):316-22. PubMed ID: 12875348
[TBL] [Abstract][Full Text] [Related]
7. Consensus Statements on the Use of Novel Formulations of Isotretinoin: A Modified Delphi Process.
Kingston P; Kircik L; Bhatia N; Del Rosso J; Desai SR; Harper JC; Gold LS; Hougeir F; Armstrong AW
J Drugs Dermatol; 2024 Jun; 23(6):429-432. PubMed ID: 38834212
[TBL] [Abstract][Full Text] [Related]
8. ABSORICA (isotretinoin): a new form.
Scheinfeld N
Skinmed; 2013; 11(2):117-9. PubMed ID: 23745231
[No Abstract] [Full Text] [Related]
9. Biopharmaceutics of 13-cis-retinoic acid (isotretinoin) formulated with modified beta-cyclodextrins.
Lin HS; Leong WW; Yang JA; Lee P; Chan SY; Ho PC
Int J Pharm; 2007 Aug; 341(1-2):238-45. PubMed ID: 17482391
[TBL] [Abstract][Full Text] [Related]
10. Single-dose bioequivalence of 105-mg fenofibric acid tablets versus 145-mg fenofibrate tablets under fasting and fed conditions: a report of two phase I, open-label, single-dose, randomized, crossover clinical trials.
Godfrey AR; Digiacinto J; Davis MW
Clin Ther; 2011 Jun; 33(6):766-75. PubMed ID: 21704241
[TBL] [Abstract][Full Text] [Related]
11. Nanocolloidal carriers of isotretinoin: antimicrobial activity against Propionibacterium acnes and dermatokinetic modeling.
Raza K; Singh B; Singla S; Wadhwa S; Garg B; Chhibber S; Katare OP
Mol Pharm; 2013 May; 10(5):1958-63. PubMed ID: 23544848
[TBL] [Abstract][Full Text] [Related]
12. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions.
Spínola AC; Almeida S; Filipe A; Neves R; Trabelsi F; Farré A
Clin Ther; 2009 Sep; 31(9):1992-2001. PubMed ID: 19843489
[TBL] [Abstract][Full Text] [Related]
13. Isotretinoin may affect pharmacokinetics of itraconazole in the skin: Is it rational to combine both for the treatment of dermatophytosis?
Srivastava A; Kothiwala SK
Indian J Dermatol Venereol Leprol; 2017; 83(1):68-69. PubMed ID: 27853005
[No Abstract] [Full Text] [Related]
14. Author's reply.
Ardeshna KP; Rohatgi S; Jerajani HR
Indian J Dermatol Venereol Leprol; 2017; 83(1):69-70. PubMed ID: 27917843
[No Abstract] [Full Text] [Related]
15. New Formulations of Isotretinoin for Acne Treatment: Expanded Options and Clinical Implications.
Bellomo R; Brunner M; Tadjally E
J Clin Aesthet Dermatol; 2021 Dec; 14(12 Suppl 1):S18-S23. PubMed ID: 35291260
[TBL] [Abstract][Full Text] [Related]
16. A new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditions.
Guivarc'h PH; Vachon MG; Fordyce D
Clin Ther; 2004 Sep; 26(9):1456-69. PubMed ID: 15531008
[TBL] [Abstract][Full Text] [Related]
17. Rationale for Use of Micronized Isotretinoin for Treatment of Acne Vulgaris: Practical Considerations and Therapeutic Advantages.
Del Rosso JQ
J Clin Aesthet Dermatol; 2023 Sep; 16(9):20-24. PubMed ID: 37720199
[TBL] [Abstract][Full Text] [Related]
18. Comparative bioavailability of 2 tablet formulations of levodopa/benserazide in healthy, fasting volunteers: a single-dose, randomized-sequence, open-label crossover study.
Keller GA; Czerniuk P; Bertuola R; Spatz JG; Assefi AR; Di Girolamo G
Clin Ther; 2011 Apr; 33(4):500-10. PubMed ID: 21635995
[TBL] [Abstract][Full Text] [Related]
19. Alpha-cyclodextrin/oil beads as a new carrier for improving the oral bioavailability of lipophilic drugs.
Trichard L; Fattal E; Besnard M; Bochot A
J Control Release; 2007 Sep; 122(1):47-53. PubMed ID: 17629584
[TBL] [Abstract][Full Text] [Related]
20. The effect of food on the absorption of oral ziprasidone.
Miceli JJ; Glue P; Alderman J; Wilner K
Psychopharmacol Bull; 2007; 40(3):58-68. PubMed ID: 18007569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
